Clinical trials
Expanded access Myelodysplastic Syndromes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| No longer available | 6 |
| Available | 3 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Barbara Ann Karmanos Cancer Institute | 1 |
| Celgene | 1 |
| Christopher Dvorak | 1 |
| Emory University | 1 |
| Geron Corporation | 1 |
| Janssen-Cilag Farmaceutica Ltda. | 1 |
| Joanne Kurtzberg, MD | 1 |
| Orca Biosystems, Inc. | 1 |
| Sellas Life Sciences Group | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 10 |
| Leukemia, Myeloid, Acute | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Hematologic Neoplasms | 3 |
| Lymphoma | 3 |
| Graft vs Host Disease | 2 |
| Immunologic Deficiency Syndromes | 2 |
| Leukemia | 2 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Precancerous Conditions | 2 |
Trials
Showing 26 to 10 of 10. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.